MDG Elects a new Board of Directors

MDG Boston Elects a New Board of Directors
The MDG Boston Nominating Committee is pleased to announce the election of a new board for a two-year term starting July 1, 2022.
Thank you to all the nominees who put in a strong candidacy for these positions. MDG Boston is stronger than ever and with this new board is positioned to continue to grow and provide the content and connections we are known for.
A big “thank you” goes to those former board members who have chosen to serve the MDG Boston community in other ways going forward:
Iris Stammberger, Joe Berkowitz, Andrea Cahill & Jerrold Shapiro

2022-2024 MDG Boston Board of Directors

  • President: Jeff Karg, MSME, Managing Director, Boston Innovation
  • Treasurer: To be Appointed
  • Secretary: Sujit Tatke, MS MBA, Program Manager, Smith & Nephew
  • Growth Strategy: Todd Astor, MD Founder & CEO, Biomembretics, Pulmonary & Critical Care Physician
  • Growth Strategy: Shinikequa White, MBA, Director, Strategic Planning, Smith & Nephew
  • Branding & Community Messaging: Ilsa Webeck, MBA, Managing Director & Founder, MedTech Strategies
  • Communications & Promotion: Steve Amato, PhD, MBA, Professor & Chair, Regulatory Affairs & Quality Assurance, Northeastern University, Principal Advisor, tJûn17 Life Science Advisors
  • Programming: Geoff Moodie, PhD, Director, Biocompatibility, Eurofins
  • Programming: Erin Cosgrove, MBA, VP, Business Development, RQM+
  • Membership:  Loretta McHugh, MBA, Director of Quality, Henke Sass Wolf of America
  • Sponsor Advocate: Judy White, MBA, Director of Marketing, Hamilton, Brook, Smith & Reynolds
  • Member Advocate: Mark Wladkowski, MS MBA, Senior VP, R&D, Smith & Nephew
  • Human Resources: Glenn Wambolt, BS, Human Resources Executive & Independent Consultant